Feeds:
Posts
Comments

Posts Tagged ‘Hormone therapy’

URO TODAY: Prostatectomy gives a far better survival rate for prostate cancer than radiation or hormone therapy, a new study found. READ MORE>

Prostatectomy for localised prostate cancer was associated with a significant and substantial reduction in mortality relative to radiation therapy and androgen-deprivation monotherapy.

Read Full Post »

URO TODAY: Hormone treatment for prostate cancer slightly raises the risk of heart problems – but not enough to discredit hormone therapy as an effective option, according to a study of 76,000 men by UK and Swedish scientists. READ MORE>

Read Full Post »

URO TODAY: Acupuncture provides excellent control of hot flashes in men undergoing androgen ablation therapy (hormone treatment) for prostate cancer, according to US researchers. READ MORE>

Read Full Post »

US NATIONAL CANCER INSTITUTE: Scientists are making progress towards finding a life-extending treatment option for men with metastatic castration-resistant prostate cancer. READ MORE>

Read Full Post »

URO TODAY: Of all cancers, prostate cancer is the most sensitive to hormones: it is thus very important to take advantage of this unique property and to always use optimal androgen blockade when hormone therapy is the appropriate treatment.  READ MORE>

Read Full Post »

URO TODAY: Acupuncture may stop hot flashes during hormone therapy for prostate cancer, according to early results in a small US trial. READ MORE>

Read Full Post »

URO TODAY: The recovery of testosterone after long-term androgen deprivation therapy for prostate cancer is slow, according to a study of about 20 patients who had been receiving hormone drugs for a mean seven years. READ MORE>

Read Full Post »

URO TODAY:  Abiraterone acetate is a promising treatment for advanced prostate cancer patients and is being tested in a Phase III trial for men with progressive castration-resistant prostate cancer who have  not had chemotherapy.

A Phase III trial for patients following prior chemotherapy has been completed and is awaiting analysis. READ MORE>

Read Full Post »

URO TODAY: Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, but there is no significant benefit for low-risk patients. READ MORE>

Read Full Post »

URO TODAY: The number of positive core samples in a biopsy for prostate cancer appears to be related to how successful hormone therapy will be later. READ MORE>

Our study of 403 patients with an overall mean follow-up of five years supports the concept of a significant association between the proportion of positive biopsy cores and the prognosis of prostate cancer treated by hormonal therapy.

Read Full Post »

Older Posts »